Related Experiment Videos
Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function
Shih-Shun Chen1, Pi-Chu Chang, Yu-Wen Cheng
1Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Abstract:
Using a transactivation-defective p53 derivative as bait, STK15, a centrosome-associated oncogenic serine/threonine kinase, was isolated as a p53 partner. The p53-STK15 interaction was confirmed further by co-immunoprecipitation and GST pull-down studies. In co-transfection experiments, p53 suppressed STK15-induced centrosome amplification and cellular transformation in a transactivation-independent manner. The suppression of STK15 oncogenic activity by p53 might be explained in part by the finding that p53 inhibited STK15 kinase activity via direct interaction with the latter's Aurora box. Taken together, these findings revealed a novel mechanism for the tumor suppressor function of p53.
Insights
The tumor suppressor p53 directly binds and inhibits the oncogenic STK15 kinase activity, revealing a new mechanism for p53
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- STK15 (Aurora kinase A) is a centrosome-associated kinase implicated in cancer.
- p53 is a critical tumor suppressor protein.
- The interaction between p53 and STK15 was previously uncharacterized.
Purpose of the Study:
- To investigate the interaction between p53 and STK15.
- To elucidate the functional consequences of this interaction.
- To identify the mechanism by which p53 may regulate STK15 activity.
Main Methods:
- Yeast two-hybrid screening using a transactivation-defective p53 mutant.
- Co-immunoprecipitation and GST pull-down assays to confirm protein interaction.
- Co-transfection experiments to assess functional effects on centrosome amplification and cellular transformation.
- In vitro kinase assays to measure STK15 activity.
Main Results:
- STK15 was identified as a binding partner of p53.
- p53 directly interacts with STK15, confirmed by biochemical methods.
- p53 suppresses STK15-induced centrosome amplification and cellular transformation independently of its transcriptional activity.
- p53 inhibits STK15 kinase activity through direct interaction with the Aurora box of STK15.
Conclusions:
- p53 directly binds to and inhibits the oncogenic kinase activity of STK15.
- This interaction represents a novel mechanism for p53's tumor suppressor function.
- Targeting the p53-STK15 interaction could offer new therapeutic strategies in cancer treatment.